Literature DB >> 28652169

Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia.

Roberto Bellelli1, Donata Vitagliano2, Giorgia Federico1, Pina Marotta3, Anna Tamburrino1, Paolo Salerno1, Orlando Paciello4, Serenella Papparella4, Jeffrey A Knauf5, James A Fagin5, Samuel Refetoff6, Giancarlo Troncone7, Massimo Santoro8.   

Abstract

Here we describe a conditional doxycycline-dependent mouse model of RET/PTC3 (NCOA4-RET) oncogene-induced thyroid tumorigenesis. In these mice, after 10 days of doxycycline (dox) administration, RET/PTC3 expression induced mitogen activated protein kinase (MAPK) stimulation and a proliferative response which resulted in the formation of hyperplastic thyroid lesions. This was followed, after 2 months, by growth arrest accompanied by typical features of oncogene-induced senescence (OIS), including upregulation of p16INK4A and p21CIP, positivity at the Sudan black B, activation of the DNA damage response (DDR) markers γH2AX and pChk2 T68, and induction of p53 and p19ARF. After 5 months, about half of thyroid lesions escaped OIS and formed tumors that remained dependent on RET/PTC3 expression. This progression was accompanied by activation of AKT-FOXO1/3a pathway and increased serum TSH levels.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AKT; Oncogene-induced senescence; RET oncogene; Thyroid cancer

Mesh:

Substances:

Year:  2017        PMID: 28652169      PMCID: PMC5741508          DOI: 10.1016/j.mce.2017.06.023

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  60 in total

Review 1.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

Review 2.  Pro-senescence therapy for cancer treatment.

Authors:  Caterina Nardella; John G Clohessy; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

3.  Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.

Authors:  Susana Gonzalez; Peter Klatt; Sonia Delgado; Esther Conde; Fernando Lopez-Rios; Montserrat Sanchez-Cespedes; Juan Mendez; Francisco Antequera; Manuel Serrano
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

4.  Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin.

Authors:  P P Roger; P Servais; J E Dumont
Journal:  J Cell Physiol       Date:  1987-01       Impact factor: 6.384

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

6.  PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a.

Authors:  Ni Zeng; Kai-Ting Yang; Jennifer-Ann Bayan; Lina He; Richa Aggarwal; Joseph W Stiles; Xiaogang Hou; Vivian Medina; Danny Abad; Beth M Palian; Ismail Al-Abdullah; Fouad Kandeel; Deborah L Johnson; Bangyan L Stiles
Journal:  Aging Cell       Date:  2013-08-06       Impact factor: 9.304

7.  Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice.

Authors:  C Ledent; J Dumont; G Vassart; M Parmentier
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

8.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

9.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

10.  Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer.

Authors:  M Saji; K Narahara; S K McCarty; V V Vasko; K M La Perle; K Porter; D Jarjoura; C Lu; S-Y Cheng; M D Ringel
Journal:  Oncogene       Date:  2011-05-02       Impact factor: 9.867

View more
  3 in total

1.  Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells.

Authors:  Stephanie Rockfield; Idhaliz Flores; Meera Nanjundan
Journal:  Oncotarget       Date:  2017-12-28

Review 2.  RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.

Authors:  Massimo Santoro; Marialuisa Moccia; Giorgia Federico; Francesca Carlomagno
Journal:  Genes (Basel)       Date:  2020-04-15       Impact factor: 4.096

Review 3.  The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis.

Authors:  Fabiana Pani; Paola Caria; Yoshinori Yasuda; Miyara Makoto; Stefano Mariotti; Laurence Leenhardt; Solmaz Roshanmehr; Patrizio Caturegli; Camille Buffet
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.